ABVC BioPharma (ABVC BioPharma) Days Sales Outstanding : 14,554.38 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is ABVC BioPharma Days Sales Outstanding?

ABVC BioPharma's average Accounts Receivable for the three months ended in Dec. 2023 was $0.32 Mil. ABVC BioPharma's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Hence, ABVC BioPharma's Days Sales Outstanding for the three months ended in Dec. 2023 was 14,554.38.

The historical rank and industry rank for ABVC BioPharma's Days Sales Outstanding or its related term are showing as below:

ABVC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 159.62 Med: 241.2 Max: 1379.32
Current: 1379.32

During the past 13 years, ABVC BioPharma's highest Days Sales Outstanding was 1379.32. The lowest was 159.62. And the median was 241.20.

ABVC's Days Sales Outstanding is ranked worse than
97.08% of 889 companies
in the Biotechnology industry
Industry Median: 71.83 vs ABVC: 1379.32

ABVC BioPharma's Days Sales Outstanding increased from Dec. 2022 (70.03) to Dec. 2023 (14,554.38).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

ABVC BioPharma Days Sales Outstanding Historical Data

The historical data trend for ABVC BioPharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABVC BioPharma Days Sales Outstanding Chart

ABVC BioPharma Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

159.62

230.49

373.71

241.20

1,042.17

ABVC BioPharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															70.03	569.60	10,478.54	3,598.67	14,554.38

Competitive Comparison of ABVC BioPharma's Days Sales Outstanding

For the Biotechnology subindustry, ABVC BioPharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABVC BioPharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ABVC BioPharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where ABVC BioPharma's Days Sales Outstanding falls into.

ABVC BioPharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

ABVC BioPharma's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.856	+	0.012)	/	2 )	/	0.152	*	365
=	0.434					/	0.152	*	365
=	1,042.17

ABVC BioPharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.626	+	0.012)	/	2 )	/	0.002	*	365 / 4
=	0.319					/	0.002	*	365 / 4
=	14,554.38

ABVC BioPharma (NAS:ABVC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

ABVC BioPharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of ABVC BioPharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

ABVC BioPharma (ABVC BioPharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABVC BioPharma Inc (NAS:ABVC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

44370 Old Warm Springs Boulevard, Fremont, CA, USA, 94538

Website

https://www.abvcpharma.com

ABVC BioPharma Inc is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Executives

Shuling Jiang	director, 10 percent owner	44370 OLD WARM SPRINGS BLVD., FREMONT CA 94538
Shih-chen Tseng	director	5F., NO. 41-1, LN. 12, SINDONG ST., SONGSHAN DIST, TAIPEI CITY F5 105065
Yoshinobu Odaira	director	4823 DUNDAS STREET, THOMDALE, LONDON X0 N6P 1J1
Norimi Sakamoto	director	4823 DUNDAS STREET, THRONDALE, LONDON X0 N6P 1J1
Shin-yu Miao	director	NO. 25-12, AMLIN RD., XITUN DIST., TAICHUNG CITY F5 407676
Tsung Shann Jiang	director, officer: CSO and Director	1197 LA PLURISSIMA PL, FREMONT CA 94539
Eugene Jiang	director, officer: Chairman of the Board & CBO	1197 LA PLURISSIMA PL, FREMONT CA 94539
Chang-jen Jiang	director	1197 LA PLURISSIMA PL, FREMONT CA 94539
Yen-hsin Chou	director	13F. NO. 2, MEISHU E. 8TH ST.,, GUSHAN DIST., KAOHSIUNG CITY F5 804413
Chi-hsin Richard King	officer: Chief Scientific Officer	11907 GRANT PLACE, SAINT LOUIS MO 63131
Howard Doong	officer: Chief Executive Officer	44370 OLD WARM SPRINGS BLVD., FREMONT CA 94538
Chihliang An	officer: Chief Financial Officer	32458 JEAN DR, UNION CITY CA 94587
Tsang Ming Jiang	director	1197 LA PURISSIMA PL, FREMONT CA 94539
Shulamit Lazar	director, 10 percent owner, officer: President,Secretary,Treasurer	8605 SANTA MONICA BOULEVARD, SUITE 41336, LOS ANGELES CA 90069
Kevin Patrick Stolz	officer: CFO & Controller	2701 CAMBRIDGE COURT, SUITE 100, AUBURN HILLS MI 48326